Journal of women's health
-
Journal of women's health · Oct 2007
Meta AnalysisDuloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trials.
To assess the efficacy (in particular, in pain, functional impairment, and quality of life) and safety and tolerability (incidence of adverse events, discontinuation rates, changes in laboratory findings, and vital signs) of duloxetine in female patients with fibromyalgia. ⋯ The pooled results of these studies demonstrate that duloxetine is a safe and efficacious treatment for both the pain and functional impairment associated with fibromyalgia in female patients, while significantly improving quality of life.